Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 27, 2022

BUY
$134.21 - $153.93 $18,252 - $20,934
136 New
136 $18,000
Q1 2022

May 04, 2022

SELL
$131.98 - $163.75 $7,390 - $9,170
-56 Closed
0 $0
Q4 2021

Jan 28, 2022

BUY
$107.43 - $135.93 $6,016 - $7,612
56 New
56 $7.58 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Absolute Capital Management, LLC Portfolio

Follow Absolute Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Absolute Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Absolute Capital Management, LLC with notifications on news.